Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > Give us a sign 📴🎣

<< Previous

Bullboard Posts

Next >>

Comment by Accept2on Jul 15, 2020 7:57am

75 Views

Post# 31269316

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Give us a sign 📴🎣

The majority of shareholders you say? Nope, count up the shareholders that make up the 50% +1. We were here long before the pandemic.......

Nomoreshells4me wrote:
Alumina partners put up money for the COVID-19 trial. I invested because of COVID-19. I'll hazard a guess that the majority of shareholders after the March 17th news release are here for the COVID-19 trial. This was a 2cent stock that shot up to .20 on the news. It's been walked down and helped down by the cro's May 11th release that things weren't going well. Then he retires debt that he's owed for 5 cent shares. Did I miss anything. All to say. The main course is the trial. Without it this would still be 2cents. Jmo

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?